Physician

John Tilynn Thompson, M.D.

According to 2025 Medicare claims, John Thompson, M.D. (NPI: 1073584439) practices ophthalmology in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Baltimore, MD. This provider's primary affiliated billing organization is THOMPSON & SJAARDA PA (NPI: 1346211935; TIN: 52-1998865) and primary practice location at 21204-6833.

Thompson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,422 traditional Medicare patients, billed 81,100 HCPCS/CPT codes, and received $4,312,133 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 414 prescription claims across 129 beneficiaries totaling $39,345 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 45 records totaling $114,052. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.3M$4.6M2015 Medicare payment: $4,390,799 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,417,899 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,319,047 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,449,861 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,575,069 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,417,239 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,530,879 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,182,912 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,970,026 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,312,133 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,22420,365$4,390,799
20161,25219,384$4,417,899
20171,20719,008$4,319,047
20181,25819,838$4,449,861
20191,37720,558$4,575,069
20201,26319,135$4,417,239
20211,42719,550$4,530,879
20221,38321,567$4,182,912
20231,36646,702$3,970,026
20241,42281,100$4,312,133

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$44K$88K2015 Drug cost: $30,271 (USD; Tot_Drug_Cst)2016 Drug cost: $36,091 (USD; Tot_Drug_Cst)2017 Drug cost: $39,161 (USD; Tot_Drug_Cst)2018 Drug cost: $87,741 (USD; Tot_Drug_Cst)2019 Drug cost: $38,313 (USD; Tot_Drug_Cst)2020 Drug cost: $46,679 (USD; Tot_Drug_Cst)2021 Drug cost: $54,536 (USD; Tot_Drug_Cst)2022 Drug cost: $54,195 (USD; Tot_Drug_Cst)2023 Drug cost: $50,779 (USD; Tot_Drug_Cst)2024 Drug cost: $39,345 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201581258$30,271
201696293$36,091
201790294$39,161
201898302$87,741
2019149364$38,313
2020190504$46,679
2021149470$54,536
2022130374$54,195
2023117360$50,779
2024129414$39,345

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system1,0791,962$93
67028Injection of drug into eye4252,449$90
92012Established patient problem focused exam of visual system277452$67
92134Imaging of retina1,3643,858$31
92201Extended exam of the back part of the eye with retinal drawing270338$19

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium491,473$16,824
Prednisolone AcetatePrednisolone Acetate1185,580$7,051
Bromfenac SodiumBromfenac Sodium37732$3,722
Timolol MaleateTimolol Maleate15806$1,605
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat503,623$978

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$590Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.23$113,462Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Tilynn Thompson, M.D.?

Tedicare shows public-source Medicare data for John Tilynn Thompson, M.D. (NPI 1073584439), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Tilynn Thompson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Tilynn Thompson, M.D.?

John Tilynn Thompson, M.D. is linked to THOMPSON & SJAARDA PA (billing NPI 1346211935) in the available physician profile data.

Does John Tilynn Thompson, M.D. have Open Payments data?

John Tilynn Thompson, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.